BNP Paribas Financial Markets lessened its stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report) by 42.2% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 164,027 shares of the semiconductor company’s stock after selling 119,899 shares during the quarter. BNP Paribas Financial Markets’ holdings in Axcelis Technologies were worth $13,178,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently bought and sold shares of ACLS. Close Asset Management Ltd purchased a new stake in Axcelis Technologies during the 3rd quarter valued at $27,000. EverSource Wealth Advisors LLC increased its stake in Axcelis Technologies by 145.1% in the second quarter. EverSource Wealth Advisors LLC now owns 451 shares of the semiconductor company’s stock worth $31,000 after purchasing an additional 267 shares during the period. Caitlin John LLC purchased a new stake in Axcelis Technologies in the third quarter worth $32,000. Advisory Services Network LLC purchased a new stake in Axcelis Technologies in the third quarter worth $32,000. Finally, Leonteq Securities AG purchased a new stake in Axcelis Technologies in the fourth quarter worth $40,000. Hedge funds and other institutional investors own 89.98% of the company’s stock.
Axcelis Technologies Price Performance
ACLS opened at $147.16 on Monday. Axcelis Technologies, Inc. has a 12-month low of $61.50 and a 12-month high of $171.61. The company has a current ratio of 4.59, a quick ratio of 2.99 and a debt-to-equity ratio of 0.04. The business’s fifty day simple moving average is $134.84 and its 200-day simple moving average is $103.53. The company has a market capitalization of $4.52 billion, a price-to-earnings ratio of 45.84, a PEG ratio of 10.42 and a beta of 1.91.
Wall Street Analyst Weigh In
A number of analysts have weighed in on ACLS shares. Zacks Research upgraded Axcelis Technologies from a “strong sell” rating to a “hold” rating in a research note on Monday, April 20th. Weiss Ratings lowered Axcelis Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Tuesday, May 12th. Finally, B. Riley Financial upgraded Axcelis Technologies from a “neutral” rating to a “buy” rating and set a $150.00 target price on the stock in a research note on Monday, April 20th. Three research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $116.25.
Check Out Our Latest Research Report on ACLS
Insider Buying and Selling at Axcelis Technologies
In other news, CEO Russell Low sold 7,468 shares of the stock in a transaction on Wednesday, May 6th. The stock was sold at an average price of $156.75, for a total transaction of $1,170,609.00. Following the transaction, the chief executive officer owned 123,570 shares of the company’s stock, valued at approximately $19,369,597.50. This represents a 5.70% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Todd Sutton sold 2,574 shares of the stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $163.89, for a total value of $421,852.86. Following the transaction, the vice president directly owned 7,817 shares in the company, valued at $1,281,128.13. The trade was a 24.77% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 36,039 shares of company stock worth $5,461,394. Insiders own 0.49% of the company’s stock.
Axcelis Technologies Company Profile
Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.
The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.
See Also
- Five stocks we like better than Axcelis Technologies
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Want to see what other hedge funds are holding ACLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report).
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
